U.S. Stroke Therapeutics Market

 

USD 3,950

* Required Fields

USD 3,950

PAY BY INVOICE

Be the first to review this product

The potential of the stroke therapies market has attracted a number of companies in the past and continues to do so. The number of players concentrating their efforts to exploit the potential of this market are increasing. The vast number of clinical trials authenticate the same. Stroke is the third leading cause of death in the U.S., and the high mortality rate makes the cost of therapy secondary.

Table of Contents

U.S. Stroke Therapeutics Market, Executive SummaryMarket OverviewObjective and PurposeScope and SegmentationStroke Patient AnalysisMajor Research FindingsSummary of Major FindingsRevenue Forecast and Segment AnalysisCompetitive AnalysisStrategic ConclusionsU.S. Stroke Therapeutics Market, Total MarketOverview and DefinitionsIntroduction and ScopeDisease Overview and HistoryRisk Factors and SymptomsTests and TreatmentsMarket DynamicsChallengesMarket Engineering AnalysisMarket DriversMarket RestraintsForecasts and TrendsDemand AnalysisRevenue ForecastsMarket and Technology TrendsPricing TrendsCompetitive AnalysisCompetitive StructureMarket Share AnalysisProduct AnalysisStrategic Recommendations Corporate Management Strategic RecommendationsMarketing Department Strategic RecommendationsResearch and Development Strategic RecommendationsMarket Engineering AwardsEntrepreneurial Company Award - Emisphere TechnologiesCompetitive Strategy Award - Sanofi-SynthelaboMarketing Engineering Leadership Award - Bristol Myers Squibb/Sanofi-SynthelaboStrategic Alliance Innovation Award - Monarch (King)Product Line Strategy Award - Sanofi-SynthelaboU.S. Stroke Therapeutics Market, Research Activities in Stroke TherapeuticsOverview and ScopeOverviewClinical TrialsEmerging ProductsEmerging AntagonistsEmerging Agonists and InhibitorsEmerging GPIIb/IIIa Platelet Inhibitor TherapyOther Emerging TherapiesCompaniesDrugs that failed in Clinical TestingCompanies Developing Stroke DrugsU.S. Stroke Therapeutics Market, Research MethodologyTerms and DefinitionsList of AbbreviationsGlossary of Terms




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 13-Dec-17

Region : North America

Release Date : 13-Dec-17

Region : North America

Release Date : 12-Dec-17

Region : North America

Release Date : 12-Dec-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.